Progyny (NASDAQ: PGNY) net income
Progyny reported a net profit of $58.5m for fiscal 2025, 7.7% more than in fiscal 2024 ($54.3m). Its net margin was 4.5%. Earnings per share were $0.68.
Progyny's best year of the last 8 was fiscal 2021. The biggest drop was in fiscal 2022, −53.8%. It reported a loss in 1 of those 8 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | $58.5m | +7.7% | 4.5% | $0.68 |
| 2024 | $54.3m | −12.4% | 4.7% | $0.59 |
| 2023 | $62.0m | +104.4% | 5.7% | $0.65 |
| 2022 | $30.4m | −53.8% | 3.9% | $0.33 |
| 2021 | $65.8m | +41.6% | 13.1% | $0.74 |
| 2020 | $46.5m | — | 13.5% | $0.54 |
| 2019 | −$8.6m | −1,396.4% | −3.7% | −$0.41 |
| 2018 | $0.7m | — | 0.6% | — |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Progyny net income compared with its sector
By net income for its latest fiscal year, Progyny ranks 130th of the 501 US health care companies with a page on Celsmar. The sector median net margin is −6.2%; that of Progyny, 4.5%.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 128th | Healthcare Services Group | $59.1m | 3.2% |
| 129th | Kiniksa Pharmaceuticals International | $59.0m | 8.7% |
| 130th | Progyny | $58.5m | 4.5% |
| 131st | LeMaitre Vascular | $57.7m | 23.1% |
| 132nd | Emergent Biosolutions | $52.6m | 7.1% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of Progyny
- How much did Progyny earn in fiscal 2025?
- Progyny reported a net profit of $58.5m for fiscal 2025. In fiscal 2024 it reported a net profit of $54.3m.
- What are the earnings per share of Progyny?
- They were $0.68 in fiscal 2025, compared with $0.59 in fiscal 2024.
- What is the net margin of Progyny?
- In fiscal 2025 its net profit was 4.5% of its revenue.
- What was the most profitable year for Progyny?
- Of its last 8 fiscal years, fiscal 2021, with $65.8m.
- Where does Progyny rank in its sector by net income?
- It ranks 130th of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for Progyny come from?
- From the annual report (Form 10-K) that Progyny files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Progyny files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018. More on Progyny: the Progyny page · annual accounts · revenue · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.